Trial · NCT00719888
Participant flow14
How many started, completed or left each group, period by period.
1 to 14 of 14
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Regimen A: High-dose TBI + Fludarabine + Cyclophosphamide | 108 | |
| Overall Study | STARTED | Regimen B: Middle-intensity TBI + Fludarabine + Cyclophosphamide + Thiotepa | 27 | |
| Overall Study | Started: Single-cord Transplant | Regimen A: High-dose TBI + Fludarabine + Cyclophosphamide | 34 | |
| Overall Study | Started: Single-cord Transplant | Regimen B: Middle-intensity TBI + Fludarabine + Cyclophosphamide + Thiotepa | 17 | |
| Overall Study | Started: Double-cord Transplant | Regimen A: High-dose TBI + Fludarabine + Cyclophosphamide | 74 | |
| Overall Study | Started: Double-cord Transplant | Regimen B: Middle-intensity TBI + Fludarabine + Cyclophosphamide + Thiotepa | 10 | |
| Overall Study | Completed: Single-cord Transplant | Regimen A: High-dose TBI + Fludarabine + Cyclophosphamide | 26 | |
| Overall Study | Completed: Single-cord Transplant | Regimen B: Middle-intensity TBI + Fludarabine + Cyclophosphamide + Thiotepa | 10 | |
| Overall Study | Completed: Double-cord Transplant | Regimen A: High-dose TBI + Fludarabine + Cyclophosphamide | 48 | |
| Overall Study | Completed: Double-cord Transplant | Regimen B: Middle-intensity TBI + Fludarabine + Cyclophosphamide + Thiotepa | 5 | |
| Overall Study | COMPLETED | Regimen A: High-dose TBI + Fludarabine + Cyclophosphamide | 74 | |
| Overall Study | COMPLETED | Regimen B: Middle-intensity TBI + Fludarabine + Cyclophosphamide + Thiotepa | 15 | |
| Overall Study | NOT COMPLETED | Regimen A: High-dose TBI + Fludarabine + Cyclophosphamide | 34 | |
| Overall Study | NOT COMPLETED | Regimen B: Middle-intensity TBI + Fludarabine + Cyclophosphamide + Thiotepa | 12 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00719888/flow